Caparrotta TM, Blackbourn LAK, McGurnaghan SJ, Chalmers J, et al. Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led
Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess
Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like
Peptide 1 Receptor Ag Diabetes Care 2020 Jun 24. pii: dc20-0120. doi: 10.2337/dc20-0120.
PMID: 32581068